1. Market Research
  2. > Pharmaceutical
  3. > Drug Delivery Market Trends
  4. > Drug Delivery Technology Market by Route of Administration, Pulmonary, Injectable, Ocular, Nasal, Topical, Implantable, Transmucosal, End User -Forecast to 2020

The drug delivery technology market is expected to reach USD 1,504.7 billion by 2020 from USD 1,048.1 billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. The market is categorized on the basis of route of administration, end user, and region. The route of administration market is further segmented into oral, pulmonary, ocular, nasal, topical, injectable, implantable and transmucosal drug delivery technology. The topical drug delivery technology market segment is expected to witness the highest CAGR in the forecast period.

Factors such as rising incidences of chronic diseases, growth of the biologics market, and innovation and technological advancements, are driving the growth of the drug delivery technology market. In addition, emphasis on innovation for improving the delivery of drugs is also contributing to the growth of the market. For instance, in February 2015, Sanofi and Mankind Corporation (U.S.) collaborated to launch Afrezza (insulin human) Inhalation Powder, inhalable insulin. This launch enabled the company to strengthen its product portfolio in nasal drug delivery. Such innovations are fueling the growth of the market.

Asia is expected to be the fastest-growing region in the drug delivery technology market. High growth in this market can be attributed to the increased population, rising prevalence of chronic diseases in the emerging markets, and existence of unmet medical needs.

Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players in the drug delivery technology market and product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms to garner a greater market, share. Firms purchasing the report can use one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

- Market Penetration: Comprehensive information on the product portfolios of the top players in the drug delivery technology market. The report analyzes this market by route of administration, end user, and geography
- Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the drug delivery technology market
- Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of leading players in the drug delivery technology market
- Market Development: Comprehensive information about lucrative markets. The report analyzes the market for various drug delivery technology market across countries
- Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the drug delivery technology market

Table Of Contents

Drug Delivery Technology Market by Route of Administration, Pulmonary, Injectable, Ocular, Nasal, Topical, Implantable, Transmucosal, End User -Forecast to 2020
TABLE OF CONTENTS

1 INTRODUCTION 21
1.1 OBJECTIVES OF THE STUDY 21
1.2 MARKET DEFINITION 21
1.3 MARKET SCOPE 22
1.3.1 MARKETS COVERED 22
1.3.2 YEARS CONSIDERED FOR THE STUDY 26
1.4 CURRENCY 26
1.5 LIMITATIONS 26
1.6 MARKET STAKEHOLDERS 26
2 RESEARCH METHODOLOGY 27
2.1 MARKET SIZE ESTIMATION 28
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 30
2.3 KEY DATA FROM SECONDARY SOURCES 32
2.4 KEY DATA FROM PRIMARY SOURCES 32
2.5 ASSUMPTIONS FOR THE STUDY 33
3 EXECUTIVE SUMMARY 34
4 PREMIUM INSIGHTS 38
4.1 DRUG DELIVERY TECHNOLOGY MARKET, BY TOPICAL DRUG DELIVERY 38
4.2 DRUG DELIVERY TECHNOLOGY MARKET, BY END USER 39
4.3 SOLID ORAL DRUG DELIVERY TECHNOLOGY MARKET, BY DOSAGE FORM 40
4.4 DRUG DELIVERY TECHNOLOGY MARKET, BY ROUTE OF ADMINISTRATION 41
4.5 GEOGRAPHIC SNAPSHOT OF THE DRUG DELIVERY TECHNOLOGY MARKET 42
5 MARKET OVERVIEW 43
5.1 INTRODUCTION 44
5.2 MARKET SEGMENTATION 44
5.2.1 MARKET SEGMENTATION, BY ROUTE OF ADMINISTRATION 44
5.2.2 MARKET SEGMENTATION, BY END USER 45
5.2.3 MARKET SEGMENTATION, BY REGION 45
5.3 MARKET DYNAMICS 46
5.4 DRIVERS 47
5.4.1 RISING PREVALENCE OF CHRONIC DISEASES 47
5.4.2 GROWTH IN THE BIOLOGICS MARKET 48
5.4.3 NEW PRODUCT LAUNCHES 49
5.4.4 DRUG INNOVATION AND TECHNOLOGICAL ADVANCEMENTS 49
5.5 RESTRAINTS 51
5.5.1 RISK OF NEEDLE-STICK INJURIES AND SIDE EFFECTS RELATED TO DRUGS 51
5.6 OPPORTUNITIES 52
5.6.1 SELF-ADMINISTRATION AND HOMECARE DRUG DELIVERY 52
5.6.2 RISING DEMAND FOR BIOSIMILARS AND GENERIC DRUGS 52
5.6.2.1 Biosimilars 52
5.6.2.2 Generic drugs 53
5.6.3 COLLABORATIONS AMONG COMPANIES 53
5.6.4 FOCUS ON OVERCOMING UNMET MEDICAL NEEDS 54
5.6.5 EMERGING MARKETS 55
5.7 CHALLENGES 56
5.7.1 PRODUCT RECALLS 56
5.7.2 PATENT EXPIRY AND PATENT CLIFF 56
5.7.3 REGULATORY HURDLES AND PRICING PRESSURE 57
6 DRUG DELIVERY TECHNOLOGY MARKET, BY ROUTE OF ADMINISTRATION 58
6.1 INTRODUCTION 59
6.2 ORAL DRUG DELIVERY 61
6.2.1 SOLID ORAL DRUGS 63
6.2.1.1 Tablets 64
6.2.1.2 Capsules 64
6.2.1.3 Powders 65
6.2.1.4 Pills 66
6.2.2 LIQUID ORAL DRUGS 66
6.2.2.1 Solutions 67
6.2.2.2 Syrups 68
6.2.3 SEMI-SOLID ORAL DRUGS 69
6.2.3.1 Gels 70
6.2.3.2 Emulsions 70
6.2.3.3 Elixirs 71
6.3 PULMONARY DRUG DELIVERY 72
6.3.1 METERED DOSE INHALERS 74
6.3.2 DRY POWDER INHALERS 75
6.3.3 NEBULIZERS 76
6.3.3.1 Jet Nebulizers 77
6.3.3.2 Ultrasonic Nebulizers 77
6.3.3.3 Soft Mist Nebulizers 78
6.4 INJECTABLE DRUG DELIVERY 79
6.4.1 INJECTABLE DRUG DELIVERY DEVICES 81
6.4.1.1 Conventional injectables 82
6.4.1.2 By Material 83
6.4.1.2.1.1 Glass 84
6.4.1.2.1.2 Plastic 85
6.4.1.3 By Product 86
6.4.1.3.1.1 Fillable Syringes 86
6.4.1.3.1.2 Prefilled Syringes 87
6.4.1.4 By Usability 88
6.4.1.4.1.1 Reusable Syringes 88
6.4.1.4.1.2 Disposable Syringes 89
6.4.1.5 Self-injection devices 89
6.4.1.6 Needle-free Injectors 91
6.4.1.7 Autoinjectors 92
6.4.1.8 Pen Injectors 92
6.4.1.9 Wearable Injectors 93
6.4.1.10 Other Devices 94
6.4.2 INJECTABLE DRUG DELIVERY FORMULATIONS 95
6.4.2.1 Conventional Drug Delivery 96
6.4.2.2 Novel Drug Delivery Formulations 97
6.4.2.3 Long-acting Injection Formulations 98
6.5 OCULAR DRUG DELIVERY 99
6.5.1 LIQUID OCULAR DRUG DELIVERY 101
6.5.1.1 Eye Drops 102
6.5.1.2 Liquid Sprays 102
6.5.2 SEMI-SOLID OCULAR DRUG DELIVERY 103
6.5.2.1 Gels 104
6.5.2.2 Eye Ointments 105
6.5.3 OCULAR DEVICES 105
6.5.3.1 Contact Lenses Coated with Drugs 106
6.5.3.2 Ocular Inserts 107
6.6 NASAL DRUG DELIVERY 108
6.6.1 NASAL DROPS 110
6.6.2 NASAL SPRAYS 110
6.6.3 NASAL POWDERS 111
6.6.4 NASAL GELS 111
6.7 TOPICAL DRUG DELIVERY 112
6.7.1 LIQUID TOPICAL DRUG DELIVERY 114
6.7.1.1 Solutions 115
6.7.1.2 Suspensions 115
6.7.2 SEMI-SOLID TOPICAL DRUG DELIVERY 116
6.7.2.1 Creams 117
6.7.2.2 Gels 118
6.7.2.3 Ointments 118
6.7.2.4 Pastes 119
6.7.2.5 Lotions 120
6.7.3 SOLID TOPICAL DRUG DELIVERY 120
6.7.3.1 Suppositories 121
6.7.3.2 Powders 122
6.7.4 TRANSDERMAL DRUG DELIVERY 122
6.7.4.1 Transdermal Patches 124
6.7.4.2 Transdermal Gels 124
6.8 IMPLANTABLE DRUG DELIVERY 125
6.8.1 ACTIVE IMPLANTABLE DRUG DELIVERY 127
6.8.2 PASSIVE IMPLANTABLE DRUG DELIVERY 128
6.9 TRANSMUCOSAL DRUG DELIVERY 129
6.9.1 ORAL TRANSMUCOSAL DRUG DELIVERY 131
6.9.1.1 Buccal Drug Delivery 132
6.9.1.2 Sublingual drug delivery 133
6.9.2 OTHER TRANSMUCOSAL DRUG DELIVERY 134
6.9.2.1 Rectal Transmucosal Drug Delivery 135
6.9.2.2 Vaginal Transmucosal Drug Delivery 135
7 DRUG DELIVERY TECHNOLOGY MARKET, BY END USER 137
7.1 INTRODUCTION 138
7.2 HOSPITALS 140
7.3 HOME CARE SETTINGS 141
7.4 AMBULATORY SURGICAL CENTERS/CLINICS 142
7.5 DIAGNOSTIC CENTERS 143
7.6 OTHER END USERS 144
8 DRUG DELIVERY TECHNOLOGY MARKET, BY REGION 145
8.1 INTRODUCTION 146
8.2 NORTH AMERICA 147
8.2.1 U.S. 150
8.2.2 CANADA 152
8.3 EUROPE 154
8.4 ASIA 157
8.5 REST OF THE WORLD 160
9 COMPETITIVE LANDSCAPE 163
9.1 OVERVIEW 163
9.2 MARKET SHARE ANALYSIS 164
9.3 COMPETITIVE SITUATIONS and TRENDS 165
9.3.1 NEW PRODUCT LAUNCHES and APPROVALS 167
9.3.2 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 168
9.3.3 ACQUISITIONS 169
9.3.4 EXPANSIONS 170
10 COMPANY PROFILES 171
(Overview, Financials, Products and Services, Strategy, and Developments)*
10.1 INTRODUCTION 171
10.2 BAYER AG 172
10.3 JOHNSON and JOHNSON SERVICES, INC. 175
10.4 NOVARTIS AG 182
10.5 PFIZER, INC. 186
10.6 F. HOFFMANN-LA ROCHE LTD. 196
10.7 3M COMPANY 204
10.8 ANTARES PHARMA, INC. 207
10.9 GLAXOSMITHKLINE PLC 209
10.10 MERCK and CO., INC. 212
10.11 SANOFI 217
*Details on Financials, Product and Services, Strategy, and Developments might not be captured in case of unlisted companies.
11 APPENDIX 222
11.1 INSIGHTS FROM INDUSTRY EXPERTS 222
11.2 DISCUSSION GUIDE 223
11.3 OTHER DEVELOPMENTS, 2012-2015 226
11.4 AVAILABLE CUSTOMIZATIONS 240
11.5 RT: REAL-TIME MARKET INTELLIGENCE 240
11.6 RELATED REPORTS 241


LIST OF TABLES

TABLE 1 LIST OF BIOLOGICS EXPECTED TO GAIN U.S. REGULATORY APPROVAL IN 2015 48
TABLE 2 MAJOR PRODUCT LAUNCHES IN 2015 49
TABLE 3 EXAMPLES OF TECHNOLOGICAL ADVANCEMENTS IN DRUG DELIVERY (2014-2015) 50
TABLE 4 RISING PREVALENCE OF CHRONIC DISEASES IS DRIVING MARKET GROWTH 50
TABLE 5 RISK OF NEEDLE-STICK INJURIES AND SIDE EFFECTS RELATED TO DRUGS ARE RESTRAINING MARKET GROWTH 51
TABLE 6 RECENT COLLABORATIONS IN THE DRUG DELIVERY TECHNOLOGY MARKET,
2014-2015 54
TABLE 7 EMERGING MARKETS EXPECTED TO OFFER SIGNIFICANT OPPORTUNITIES FOR MARKET PLAYERS 55
TABLE 8 MAJOR PRODUCT RECALLS IN THE DRUG DELIVERY TECHNOLOGY MARKET, 2015 56
TABLE 9 PATENT EXPIRY OF DRUGS, 2014-2015 56
TABLE 10 PRODUCT RECALLS POSE A SIGNIFICANT CHALLENGE FOR MARKET GROWTH 57
TABLE 11 DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2013-2020 (USD BILLION) 60
TABLE 12 DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 60
TABLE 13 ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM,
2013-2020 (USD BILLION) 62
TABLE 14 ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 62
TABLE 15 ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR SOLID DRUGS,
BY DOSAGE FORM, 2013-2020 (USD BILLION) 63
TABLE 16 ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR SOLID DRUGS,
BY REGION, 2013-2020 (USD BILLION) 63
TABLE 17 SOLID ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR TABLETS,
BY REGION, 2013-2020 (USD BILLION) 64
TABLE 18 SOLID ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR CAPSULES,
BY REGION, 2013-2020 (USD BILLION) 65
TABLE 19 SOLID ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR POWDERS,
BY REGION, 2013-2020 (USD BILLION) 65
TABLE 20 SOLID ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR PILLS,
BY REGION, 2013-2020 (USD BILLION) 66
TABLE 21 LIQUID ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2013-2020 (USD BILLION) 66
TABLE 22 LIQUID ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 67
TABLE 23 LIQUID ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR SOLUTIONS,
BY REGION, 2013-2020 (USD BILLION) 68
TABLE 24 LIQUID ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR SYRUPS,
BY REGION, 2013-2020 (USD BILLION) 68
TABLE 25 SEMI-SOLID ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2013-2020 (USD BILLION) 69
TABLE 26 SEMI-SOLID ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2013-2020 (USD BILLION) 69
TABLE 27 SEMI-SOLID ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR GELS,
BY REGION, 2013-2020 (USD BILLION) 70
TABLE 28 SEMI-SOLID ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR EMULSIONS, BY REGION, 2013-2020 (USD BILLION) 71
TABLE 29 SEMI-SOLID ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR ELIXIRS,
BY REGION, 2013-2020 (USD BILLION) 71
TABLE 30 PULMONARY DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2013-2020 (USD BILLION) 73
TABLE 31 PULMONARY DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 73
TABLE 32 PULMONARY DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR METERED DOSE INHALERS, BY REGION, 2013-2020 (USD BILLION) 74
TABLE 33 PULMONARY DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR DRY POWDER INHALERS, BY REGION, 2013-2020 (USD BILLION) 75
TABLE 34 PULMONARY DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR NEBULIZERS,
BY DOSAGE FORM, 2013-2020 (USD BILLION) 76
TABLE 35 PULMONARY DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR NEBULIZERS,
BY REGION, 2013-2020 (USD BILLION) 76
TABLE 36 JET NEBULIZERS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION) 77
TABLE 37 ULTRASONIC NEBULIZERS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION) 78
TABLE 38 SOFT MIST NEBULIZERS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION) 78
TABLE 39 INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2013-2020 (USD BILLION) 80
TABLE 40 INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 81
TABLE 41 INJECTABLE DRUG DELIVERY DEVICES MARKET SIZE, BY TYPE,
2013-2020 (USD BILLION) 81
TABLE 42 INJECTABLE DRUG DELIVERY DEVICES MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 82
TABLE 43 INJECTABLE DRUG DELIVERY DEVICES MARKET SIZE FOR CONVENTIONAL INJECTABLES, BY REGION, 2013-2020 (USD BILLION) 83
TABLE 44 INJECTABLE DRUG DELIVERY DEVICES MARKET SIZE FOR CONVENTIONAL INJECTABLES, BY MATERIAL, 2013-2020 (USD BILLION) 83
TABLE 45 CONVENTIONAL GLASS INJECTION DEVICES MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 84
TABLE 46 CONVENTIONAL PLASTIC INJECTION DEVICES MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 85
TABLE 47 INJECTABLE DRUG DELIVERY DEVICES MARKET SIZE FOR CONVENTIONAL INJECTABLES, BY PRODUCT, 2013-2020 (USD BILLION) 86
TABLE 48 CONVENTIONAL FILLABLE SYRINGES MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 86
TABLE 49 CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 87
TABLE 50 INJECTABLE DRUG DELIVERY DEVICES MARKET SIZE FOR CONVENTIONAL INJECTABLES, BY USABILITY, 2013-2020 (USD BILLION) 88
TABLE 51 CONVENTIONAL REUSABLE SYRINGES MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 88
TABLE 52 CONVENTIONAL DISPOSABLE SYRINGES MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 89
TABLE 53 INJECTABLE DRUG DELIVERY DEVICES MARKET SIZE FOR SELF-INJECTION DEVICES, BY TYPE, 2013-2020 (USD BILLION) 90
TABLE 54 INJECTABLE DRUG DELIVERY DEVICES MARKET SIZE FOR SELF-INJECTION DEVICES, BY REGION, 2013-2020 (USD BILLION) 90
TABLE 55 NEEDLE-FREE INJECTORS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION) 91
TABLE 56 AUTOINJECTORS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION) 92
TABLE 57 PEN INJECTORS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION) 93
TABLE 58 WEARABLE INJECTORS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION) 94
TABLE 59 OTHER DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD BILLION) 94
TABLE 60 INJECTABLE DRUG DELIVERY FORMULATIONS MARKET SIZE, BY TYPE,
2013-2020 (USD BILLION) 95
TABLE 61 INJECTABLE DRUG DELIVERY FORMULATIONS MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 96
TABLE 62 CONVENTIONAL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION) 96
TABLE 63 NOVEL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 97
TABLE 64 LONG-ACTING INJECTION FORMULATIONS MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 98
TABLE 65 OCULAR DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM,
2013-2020 (USD BILLION) 100
TABLE 66 OCULAR DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 100
TABLE 67 LIQUID OCULAR DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2013-2020 (USD BILLION) 101
TABLE 68 LIQUID OCULAR DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 101
TABLE 69 LIQUID OCULAR DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR EYE DROPS,
BY REGION, 2013-2020 (USD BILLION) 102
TABLE 70 LIQUID OCULAR DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR LIQUID SPRAYS, BY REGION, 2013-2020 (USD BILLION) 103
TABLE 71 SEMI-SOLID OCULAR DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2013-2020 (USD BILLION) 103
TABLE 72 SEMI-SOLID OCULAR DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2013-2020 (USD BILLION) 104
TABLE 73 SEMI-SOLID OCULAR DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR GELS,
BY REGION, 2013-2020 (USD BILLION) 104
TABLE 74 SEMI-SOLID OCULAR DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR EYE OINTMENTS, BY REGION, 2013-2020 (USD BILLION) 105
TABLE 75 OCULAR DEVICES DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2013-2020 (USD BILLION) 105
TABLE 76 OCULAR DEVICES DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2013-2020 (USD BILLION) 106
TABLE 77 CONTACT LENS COATED WITH DRUGS MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 106
TABLE 78 OCULAR INSERTS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION) 107
TABLE 79 NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM,
2013-2020 (USD BILLION) 109
TABLE 80 NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 109
TABLE 81 NASAL DROPS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION) 110
TABLE 82 NASAL SPRAYS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION) 110
TABLE 83 NASAL POWDERS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION) 111
TABLE 84 NASAL GELS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION) 111
TABLE 85 TOPICAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM,
2013-2020 (USD BILLION) 113
TABLE 86 TOPICAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 113
TABLE 87 LIQUID TOPICAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2013-2020 (USD BILLION) 114
TABLE 88 LIQUID TOPICAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 114
TABLE 89 TOPICAL DRUG DELIVERY SOLUTIONS MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 115
TABLE 90 TOPICAL DRUG DELIVERY SUSPENSIONS MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 116
TABLE 91 SEMI-SOLID TOPICAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2013-2020 (USD BILLION) 116
TABLE 92 SEMI-SOLID TOPICAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2013-2020 (USD BILLION) 117
TABLE 93 TOPICAL DRUG DELIVERY CREAMS MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 117
TABLE 94 TOPICAL DRUG DELIVERY GELS MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 118
TABLE 95 TOPICAL DRUG DELIVERY OINTMENTS MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 118
TABLE 96 TOPICAL DRUG DELIVERY PASTES MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 119
TABLE 97 TOPICAL DRUG DELIVERY LOTIONS MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 120
TABLE 98 SOLID TOPICAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2013-2020 (USD BILLION) 120
TABLE 99 SOLID TOPICAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 121
TABLE 100 TOPICAL DRUG DELIVERY SUPPOSITORIES MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 121
TABLE 101 TOPICAL DRUG DELIVERY POWDERS MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 122
TABLE 102 TRANSDERMAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2013-2020 (USD BILLION) 123
TABLE 103 TRANSDERMAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 123
TABLE 104 TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2013-2020 (USD BILLION) 124
TABLE 105 TRANSDERMAL GELS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION) 124
TABLE 106 IMPLANTABLE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2013-2020 (USD BILLION) 126
TABLE 107 IMPLANTABLE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 127
TABLE 108 ACTIVE IMPLANTABLE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2013-2020 (USD BILLION) 127
TABLE 109 PASSIVE IMPLANTABLE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2013-2020 (USD BILLION) 128
TABLE 110 TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2013-2020 (USD BILLION) 130
TABLE 111 TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 131
TABLE 112 ORAL TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2013-2020 (USD BILLION) 131
TABLE 113 ORAL TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2013-2020 (USD BILLION) 132
TABLE 114 BUCCAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 132
TABLE 115 SUBLINGUAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 133
TABLE 116 OTHER TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET SIZE,
BY DOSAGE FORM, 2013-2020 (USD BILLION) 134
TABLE 117 OTHER TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET SIZE,
BY REGION, 2013-2020 (USD BILLION) 134
TABLE 118 RECTAL TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET SIZE,
BY REGION, 2013-2020 (USD BILLION) 135
TABLE 119 VAGINAL TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET SIZE,
BY REGION, 2013-2020 (USD BILLION) 136
TABLE 120 DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER,
2013-2020 (USD BILLION) 139
TABLE 121 DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 139
TABLE 122 DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR HOSPITALS, BY REGION,
2013-2020 (USD BILLION) 140
TABLE 123 DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR HOME CARE SETTINGS,
BY REGION, 2013-2020 (USD BILLION) 141
TABLE 124 DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR AMBULATORY SURGICAL CENTERS/CLINICS, BY REGION, 2013-2020 (USD BILLION) 142
TABLE 125 DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR DIAGNOSTIC CENTERS,
BY REGION, 2013-2020 (USD BILLION) 143
TABLE 126 DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR OTHER END USERS, BY REGION, 2013-2020 (USD BILLION) 144
TABLE 127 DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION,
2013-2020 (USD BILLION) 146
TABLE 128 NORTH AMERICA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2013-2020 (USD BILLION) 149
TABLE 129 NORTH AMERICA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2013-2020 (USD BILLION) 149
TABLE 130 NORTH AMERICA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2013-2020 (USD BILLION) 150
TABLE 131 U.S.: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2013-2020 (USD BILLION) 151
TABLE 132 U.S.: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER,
2013-2020 (USD BILLION) 151
TABLE 133 CANADA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2013-2020 (USD BILLION) 152
TABLE 134 CANADA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER,
2013-2020 (USD BILLION) 153
TABLE 135 EUROPE: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2013-2020 (USD BILLION) 156
TABLE 136 EUROPE: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER,
2013-2020 (USD BILLION) 156
TABLE 137 ASIA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2013-2020 (USD BILLION) 159
TABLE 138 ASIA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER,
2013-2020 (USD BILLION) 159
TABLE 139 ROW: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2013-2020 (USD BILLION) 162
TABLE 140 ROW: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER,
2013-2020 (USD BILLION) 162
TABLE 141 NEW PRODUCT LAUNCHES and APPROVALS, 2012-2015 167
TABLE 142 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS, 2012-2015 168
TABLE 143 ACQUISITIONS, 2012-2015 169
TABLE 144 EXPANSIONS, 2012-2015 170



LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 27
FIGURE 2 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 29
FIGURE 3 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 29
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 30
FIGURE 5 DATA TRIANGULATION METHODOLOGY 31
FIGURE 6 DRUG DELIVERY TECHNOLOGY MARKET, BY ROUTE OF ADMINISTRATION
(2015 VS. 2020) 34
FIGURE 7 ORAL DRUG DELIVERY TECHNOLOGY MARKET, BY DOSAGE FORM, 2015 VS. 2020 35
FIGURE 8 HOSPITALS FORM THE LARGEST END-USER SEGMENT 36
FIGURE 9 TOPICAL DRUG DELIVERY TECHNOLOGY MARKET, BY DOSAGE FORM,
2015 VS. 2020 36
FIGURE 10 TOPICAL DRUG DELIVERY SEGMENT TO GROW AT THE HIGHEST CAGR FROM 2015 TO 2020 38
FIGURE 11 HOSPITALS SEGMENT TO DOMINATE MARKET IN THE FORECAST PERIOD 39
FIGURE 12 TABLETS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE IN 2015 40
FIGURE 13 INJECTABLE DRUG DELIVERY TECHNOLOGY TO OFFER SIGNIFICANT CONTRIBUTION TO THE OVERALL MARKET GROWTH (2015-2020) 41
FIGURE 14 ASIA TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD 42
FIGURE 15 DRUG DELIVERY TECHNOLOGY MARKET SEGMENTATION, BY ROUTE OF ADMINISTRATION 44
FIGURE 16 DRUG DELIVERY TECHNOLOGY MARKET SEGMENTATION, BY END USER 45
FIGURE 17 DRUG DELIVERY TECHNOLOGY MARKET SEGMENTATION, BY REGION 45
FIGURE 18 DRUG DELIVERY TECHNOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 46
FIGURE 19 TOPICAL DRUG DELIVERY TO WITNESS HIGHEST GROWTH IN THE FORECAST PERIOD 59
FIGURE 20 SOLID ORAL DRUG DELIVERY TO WITNESS HIGHEST GROWTH IN THE FORECAST PERIOD 61
FIGURE 21 NEBULIZERS TO WITNESS HIGHEST GROWTH IN THE FORECAST PERIOD 72
FIGURE 22 FORMULATIONS TO WITNESS HIGHEST GROWTH IN THE FORECAST PERIOD 80
FIGURE 23 LIQUID OCULAR DRUG DELIVERY TO WITNESS HIGHEST GROWTH IN THE FORECAST PERIOD 99
FIGURE 24 NASAL SPRAYS TO WITNESS HIGHEST GROWTH IN THE FORECAST PERIOD 108
FIGURE 25 SEMI-SOLID TOPICAL DRUG DELIVERY TO WITNESS HIGHEST GROWTH IN THE FORECAST PERIOD 112
FIGURE 26 PASSIVE IMPLANTABLE DRUG DELIVERY TO WITNESS HIGHEST GROWTH IN THE FORECAST PERIOD 126
FIGURE 27 ORAL TRANSMUCOSAL DRUG DELIVERY TO WITNESS HIGHEST GROWTH IN THE FORECAST PERIOD 130
FIGURE 28 DRUG DELIVERY TECHNOLOGY MARKET SEGMENTATION, BY END USER 138
FIGURE 29 DRUG DELIVERY TECHNOLOGY MARKET, BY END USER: HOSPITALS TO HOLD LARGEST MARKET SHARE IN 2015 138
FIGURE 30 NORTH AMERICA TO HOLD THE LARGEST SHARE OF THE GLOBAL DRUG DELIVERY TECHNOLOGY MARKET (2015) 148
FIGURE 31 EUROPEAN DRUG DELIVERY TECHNOLOGY MARKET SNAPSHOT (2015) 155
FIGURE 32 ASIA TO BE THE FASTEST-GROWING REGIONAL SEGMENT OF THE GLOBAL DRUG DELIVERY TECHNOLOGY MARKET (2015) 158
FIGURE 33 RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE THE GROWTH OF THE DRUG DELIVERY TECHNOLOGY MARKET IN THE ROW (2015) 161
FIGURE 34 NEW PRODUCT LAUNCHES and APPROVALS IS THE KEY GROWTH STRATEGY ADOPTED BY PLAYERS IN THE DRUG DELIVERY MARKET DURING THE STUDIED PERIOD (2014-2015) 163
FIGURE 35 GLOBAL DRUG DELIVERY TECHNOLOGY MARKET SHARE, BY KEY PLAYER (2014) 164
FIGURE 36 MARKET EVOLUTION FRAMEWORK: NEW PRODUCT LAUNCHES and APPROVALS ARE FUELING MARKET GROWTH 165
FIGURE 37 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES and APPROVALS IS THE KEY GROWTH STRATEGY ADOPTED BY LEADING PLAYERS IN 2015 166
FIGURE 38 GEOGRAPHIC REVENUE MIX FOR THE TOP 5 PLAYERS 171
FIGURE 39 BAYER AG: COMPANY SNAPSHOT 172
FIGURE 40 JOHNSON and JOHNSON SERVICES, INC.: COMPANY SNAPSHOT 175
FIGURE 41 NOVARTIS AG: COMPANY SNAPSHOT 182
FIGURE 42 PFIZER, INC.: COMPANY SNAPSHOT 186
FIGURE 43 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT 196
FIGURE 44 3M COMPANY: COMPANY SNAPSHOT 204
FIGURE 45 ANTARES PHARMA, INC: COMPANY SNAPSHOT 207
FIGURE 46 GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT 209
FIGURE 47 MERCK and CO., INC.: COMPANY SNAPSHOT 212
FIGURE 48 SANOFI: COMPANY SNAPSHOT 217

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
European Market Report for Peripheral Intravenous Catheters 2017 - MedCore

European Market Report for Peripheral Intravenous Catheters 2017 - MedCore

  • $ 6495
  • Industry report
  • November 2016
  • by iData Research, Inc.

Description The European PIVC market includes three segments: conventional PIVCs, safety PIVCs and midlines. The safety PIVC segment includes three sub-segments: active safety PIVCs, passive safety PIVCs ...

North American Drug Delivery Technologies Market by Route of Administration, Pulmonary, Injectable, Ocular, Nasal, Topical, Implantable), End User - Global Forecast to 2021

North American Drug Delivery Technologies Market by Route of Administration, Pulmonary, Injectable, Ocular, Nasal, Topical, Implantable), End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The North American drug delivery technologies market is projected to reach USD 758.7 billion by 2021 from USD 520.0 billion in 2016, at a CAGR of 6.5% during the forecast period. Major factors contributing ...

Syringes Market by Usability & Disposable Syringes), Material, Type - Global Forecast to 2021

Syringes Market by Usability & Disposable Syringes), Material, Type - Global Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

The syringes market is expected to reach USD 15.99 billion by 2021, at a CAGR of 8.7% from 2016 to 2021. The syringes market is primarily driven by the high prevalence of chronic diseases across the globe. ...

Global Polymeric Foams Industry

October 2016 $ 4950

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.